Announced Mon, 29 Jun · 19:45 IST
Promoter declares no encumbrance on shares for FY2025-26
Ownership Changes View source PDF
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.6%1-day move
₹166.50
prior close
₹167.48
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.3-0.2-0.3+1.6+1.4+5.5+7.0+5.1+3.4+11.3———
Up moveDown movePending
AI summary
Ajay G. Piramal, on behalf of the Promoter and Promoter Group, has filed a declaration under SEBI Takeover Regulations confirming that no encumbrance (pledge or otherwise) was created on any shares or securities of Piramal Pharma Limited during financial year 2025-26. This is a routine annual compliance filing required under Regulation 31(4).
Likely market impact
Reassuring for shareholders as it confirms promoters have not pledged shares, indicating no immediate funding pressure or risk.